Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1021-2020Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1020-2020Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1019-2020Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1018-2020Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1017-2020Class IITerminatedMar 25, 2020Regular Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1016-2020Class IITerminatedMar 25, 2020Regular Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1015-2020Class IITerminatedMar 25, 2020Regular Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1014-2020Class IITerminatedMar 25, 2020Regular Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1013-2020Class IITerminatedMar 25, 2020Regular Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1012-2020Class IITerminatedMar 18, 2020Levonorgestrel and Ethinyl Estradiol Tablets USPFailed Content Uniformity Specifications: Out Of Specification test results observed for content uniformity.Lupin Pharmaceuticals Inc. · D-1056-2020Class IIITerminatedMar 18, 2020BekyreeFailed Content Uniformity Specifications: Out Of Specification test results observed for content and blend uniformity.Lupin Pharmaceuticals Inc. · D-1055-2020Class IITerminatedMar 18, 2020Morphine SulfateLack Of Processing ControlsRedline Pharmacy Solutions · D-1011-2020Class IITerminatedMar 18, 2020Vancomycin 900MG in 100ML 0.9% NACL InjectableLack Of Processing ControlsRedline Pharmacy Solutions · D-1010-2020Class IITerminatedMar 18, 2020Ertapenem in 100ML 0.9% NACL 1GM InjectableLack Of Processing ControlsRedline Pharmacy Solutions · D-1009-2020Class IITerminatedMar 18, 2020DaptomycinLack Of Processing ControlsRedline Pharmacy Solutions · D-1008-2020Class IITerminatedMar 18, 2020Morphine SulfateLack Of Processing ControlsRedline Pharmacy Solutions · D-1007-2020Class IITerminatedMar 18, 2020Acetylcysteine Ophthalmic 10% SolutionLack Of Processing ControlsRedline Pharmacy Solutions · D-1006-2020Class IITerminatedMar 18, 2020Acetaminophen 500 mg tabletPresence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg...H J Harkins Company Inc dba Pharma Pac · D-1005-2020Class IITerminatedMar 18, 2020Ranitidine Oral SolutionCGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.Precision Dose Inc. · D-1004-2020Class IITerminatedMar 18, 2020Ranitidine TabletsCGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.American Health Packaging · D-1003-2020Class IIITerminatedMar 18, 2020Quetiapine Fumarate Extended-Release TabletsLabeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release...The Harvard Drug Group · D-1002-2020Class IIITerminatedMar 18, 2020Quetiapine Fumarate Extended-Release TabletsLabeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release...The Harvard Drug Group · D-1001-2020Class IIITerminatedMar 18, 2020Quetiapine Fumarate Extended-Release TabletsLabeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release...The Harvard Drug Group · D-1000-2020Class IIITerminatedMar 18, 2020Quetiapine Fumarate Extended-Release TabletsLabeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release...The Harvard Drug Group · D-0999-2020Class IITerminatedMar 18, 2020Carbidopa and Levodopa TabletsProduct Mix-Up: A foreign tablet was found in bottle.Mayne Pharma Inc · D-0998-2020Class IITerminatedMar 18, 2020Sunstar GUM Toothpaste 3 g tubescGMP DeviationSunstar Guangzhou Ltd. · D-0997-2020Class IITerminatedMar 11, 2020ElelysoLack of Assurance of Sterility--Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the...Pfizer Inc. · D-0995-2020Class IITerminatedMar 11, 2020Zinc Chloride InjectionLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0994-2020Class IITerminatedMar 11, 2020CholecalciferolLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0993-2020Class IITerminatedMar 11, 2020CholecalciferolLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0992-2020Class IITerminatedMar 11, 2020Triamcinolone Diacetate Injectable SuspensionLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0991-2020Class IITerminatedMar 11, 2020Triamcinolone Diacetate Injectable SuspensionLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0990-2020Class IITerminatedMar 11, 2020Triamcinolone Diacetate Injectable SuspensionLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0989-2020Class IITerminatedMar 11, 2020Triamcinolone AcetonideLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0988-2020Class IITerminatedMar 11, 2020Triamcinolone AcetonideLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0987-2020Class IITerminatedMar 11, 2020Triamcinolone Acetonide/Bupivacaine Hydrochloride Injectable SuspensionLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0986-2020Class IITerminatedMar 11, 2020Testosterone Cypionate/Progesterone InjectionLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0985-2020Class IITerminatedMar 11, 2020Testosterone Cypionate InjectionLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0984-2020Class IITerminatedMar 11, 2020Testosterone Cypionate InjectionLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0983-2020